The Roche Group is a Switzerland-based multinational pharma titan.In the US,it trades via the OTC pink sheets.Monday's performance was good, closing at 44.25,a gain of 1.41 (3.25%). The stock has a dividend yield of 2.65%.*
The company today received FDA emergency approval of its COVID-19 antibody test, which the firm says is nearby 100% accurate. According to CEO Severin Schwan of Austria:
From a technology point of view,it is much easier to ramp up antibody tests versus molecular tests.So I'm confident we will be able to provide this test in high quantities, and that this will allow the testing of broader parts of the population.Just to put this in perspective,in May alone, Roche will ramp up its production into the high double digit millions of tests per month.*
The FDA has only given twelve antibody test approvals despite hundreds of prospects.*
Roche Holding AG (RHHBY:OTCMKTS)
No comments:
Post a Comment